1006-298X
2015 Issue 1
Treatment of secondary hyperparathyroidism in hemodilysis patients by paricalcitol
WANG Taina;,XU Bin;,JIA Fengyu;,ZHANG Haitao;,GONG Dehua;,LIU Zhihong;
WANG Taina;,XU Bin;,JIA Fengyu;,ZHANG Haitao;,GONG Dehua;,LIU Zhihong;
..............page:1-5
Rivaroxaban in the treatment of nephrotic patients with thromboembolism
ZHANG Lihua;,ZHANG Jiong;,TIAN Hong;,LIANG Ju;,ZHANG Haitao;,LIU Zhihong;
ZHANG Lihua;,ZHANG Jiong;,TIAN Hong;,LIANG Ju;,ZHANG Haitao;,LIU Zhihong;
..............page:6-10
Patients with acute kidney injury after acute myocardial infarction not associated with cardiac surgery
SUN Yanbei;,TAO Ynan;,ZOU Yun;,YANG Min;
SUN Yanbei;,TAO Ynan;,ZOU Yun;,YANG Min;
..............page:11-15
Early diagnosis and treatment evaluation on patients with transplant renal artery stenosis
wang suo gang ;, chen zhu ;, zuo lin ping ;, miao niu ;, cheng liu hui ;, cui yong ;, he wei ;, wang guang ce ;
wang suo gang ;, chen zhu ;, zuo lin ping ;, miao niu ;, cheng liu hui ;, cui yong ;, he wei ;, wang guang ce ;
..............page:16-20
Post-transplantation diabetes mellitus and the risk factors
WANG Yingji;,DI Wenjia;,SUN Qin;,YANG Hongji;,CHEN Ping;
WANG Yingji;,DI Wenjia;,SUN Qin;,YANG Hongji;,CHEN Ping;
..............page:21-25
Declination of residual renal function in peritoneal dialysis patients with different baseline residual renal function
yin fei ting ;, zuo zuo ;, sun hong qin ;, zhou zuo zuo ;, zhou yan ;, zhou yu chao ;, liu zhi hong ;, yu yu sheng ;
yin fei ting ;, zuo zuo ;, sun hong qin ;, zhou zuo zuo ;, zhou yan ;, zhou yu chao ;, liu zhi hong ;, yu yu sheng ;
..............page:26-31
Clinico-pathological characteristics and outcome of patients with biopsy-proven hypertensive nephrosclerosis
liang shao zuo ;, le wei bo ;, liang dan dan ;, chen hao ;, xu feng ;, chen hui ping ;, liu zhi hong ;, zeng cai hong ;
liang shao zuo ;, le wei bo ;, liang dan dan ;, chen hao ;, xu feng ;, chen hui ping ;, liu zhi hong ;, zeng cai hong ;
..............page:32-37
The model of renal injury by inhaling xylene in rats
XU Zhongxiu;,CAO Xianghua;,WANG Shengyu;,ZENG Caihong;,ZHU Xiaodong;,LIU Zhihong;,QIN Weisong;
XU Zhongxiu;,CAO Xianghua;,WANG Shengyu;,ZENG Caihong;,ZHU Xiaodong;,LIU Zhihong;,QIN Weisong;
..............page:38-43
Role of prostaglandin E2 receptor subtype 1 on TGF-β1-induced mouse mesangial cell
MA Wen;,XU Yuyin;,QIU Zhi;,FAN Yaping;,CHEN Xiaolan;
MA Wen;,XU Yuyin;,QIU Zhi;,FAN Yaping;,CHEN Xiaolan;
..............page:44-49
che chu ji su , xu yao cong yi shu bian wei ke xue
zhu tong yu ;
zhu tong yu ;
..............page:50-51
shen yi zhi shou zhe shu hou ji su che jian de ti hui
chen jin song ;
chen jin song ;
..............page:51-52
shen yi zhi shu hou che ting ji su de ti hui
zhang ke qin ;
zhang ke qin ;
..............page:52-53
Autoimmune disease coinciding with systemic light chain amyloidosis
LIANG Dandan;,ZENG Caihong;
LIANG Dandan;,ZENG Caihong;
..............page:53-53,90,91,92,93
Integrins and kidney disease
SHI Wenchao;
SHI Wenchao;
..............page:54-58
..............page:59-64
..............page:65-69
..............page:70-74
..............page:75-79
..............page:80-84
..............page:85-89
Rapidly progressive glomerulonephritis and intracranial hemorrhage
ZUO Ke;,XIE Honglang;,LIU Zhihong;
ZUO Ke;,XIE Honglang;,LIU Zhihong;
..............page:94-98
..............page:99-100